| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report
|
Pisa, M.
|
|
|
27 |
C |
p. 403-405
|
artikel
|
| 2 |
Acute epileptic seizures in myelin oligodendrocyte glycoprotein encephalomyelitis and neuromyelitis optica spectrum disorder: A comparative cohort study
|
Yao, Yuan
|
|
|
27 |
C |
p. 281-288
|
artikel
|
| 3 |
Acute vision loss in multiple sclerosis: Optic neuritis or central serous chorioretinopathy?
|
Abtahi, Mohammad-Ali
|
|
|
27 |
C |
p. 147-150
|
artikel
|
| 4 |
A first investigation of tongue, lip, and jaw movements in persons with dysarthria due to multiple sclerosis
|
Mefferd, Antje S
|
|
|
27 |
C |
p. 188-194
|
artikel
|
| 5 |
Animal exposure over the life-course and risk of multiple sclerosis: A case-control study within two cohorts of US women
|
de Jong, Hilda J.I.
|
|
|
27 |
C |
p. 327-332
|
artikel
|
| 6 |
Anxiety and depression in patients with multiple sclerosis: The mediating effects of perceived social support
|
Henry, Audrey
|
|
|
27 |
C |
p. 46-51
|
artikel
|
| 7 |
Aphasic status epilepticus preceding tumefactive left hemisphere lesion in anti-MOG antibody associated disease
|
Katsuse, Kazuto
|
|
|
27 |
C |
p. 91-94
|
artikel
|
| 8 |
A rare P2RX7 variant in a Hungarian family with multiple sclerosis
|
Zrzavy, Tobias
|
|
|
27 |
C |
p. 340-341
|
artikel
|
| 9 |
Are there any clinical and electrocardiographic predictors of heart rate reduction in relapsing- remitting multiple sclerosis patients treated with fingolimod?
|
Kocyigit, Duygu
|
|
|
27 |
C |
p. 276-280
|
artikel
|
| 10 |
Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.
|
Lorefice, L.
|
|
|
27 |
C |
p. 74-78
|
artikel
|
| 11 |
Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations
|
Narayan, Ram N
|
|
|
27 |
C |
p. 30-33
|
artikel
|
| 12 |
Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review
|
Shahmohammadi, Sareh
|
|
|
27 |
C |
p. 350-363
|
artikel
|
| 13 |
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis
|
Buonomo, Antonio Riccardo
|
|
|
27 |
C |
p. 44-45
|
artikel
|
| 14 |
Blood lead levels and multiple sclerosis: A case-control study
|
Dehghanifiroozabadi, Mohammad
|
|
|
27 |
C |
p. 151-155
|
artikel
|
| 15 |
Cardiorespiratory fitness and cognitive processing speed in multiple sclerosis: The possible roles of psychological symptoms
|
Sandroff, Brian M.
|
|
|
27 |
C |
p. 23-29
|
artikel
|
| 16 |
Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study
|
Rejdak, Konrad
|
|
|
27 |
C |
p. 117-120
|
artikel
|
| 17 |
Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD)
|
Fragoso, Yara Dadalti
|
|
|
27 |
C |
p. 392-396
|
artikel
|
| 18 |
Coexistence of Multiple Sclerosis and Alzheimer's disease: A review
|
Luczynski, Pauline
|
|
|
27 |
C |
p. 232-238
|
artikel
|
| 19 |
Color Doppler imaging evaluation of blood flow parameters in ophthalmic and posterior ciliary arteries and optic nerve diameter in chronic optic neuritis in multiple sclerosis patients
|
Amini, Hassan
|
|
|
27 |
C |
p. 195-199
|
artikel
|
| 20 |
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US
|
Ontaneda, Daniel
|
|
|
27 |
C |
p. 101-111
|
artikel
|
| 21 |
Comparing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) and non MOG-Ab associated optic neuritis: Clinical course and treatment outcome
|
Etemadifar, Masoud
|
|
|
27 |
C |
p. 127-130
|
artikel
|
| 22 |
Concurrence of juvenile idiopathic arthritis and primary demyelinating disease in a young child
|
Coşkun, Ayşe Nur
|
|
|
27 |
C |
p. 20-22
|
artikel
|
| 23 |
Corpus callosum agenesis and clinically isolated syndrome (CIS): A case report
|
Naser Moghadasi, Abdorreza
|
|
|
27 |
C |
p. 342-343
|
artikel
|
| 24 |
Decision-making on radiologically isolated syndrome among Argentinean neurologists: A survey based on clinical experience
|
Carnero Contentti, Edgar
|
|
|
27 |
C |
p. 61-64
|
artikel
|
| 25 |
Diabetes and anxiety adversely affect cognition in multiple sclerosis
|
Marrie, Ruth Ann
|
|
|
27 |
C |
p. 164-170
|
artikel
|
| 26 |
Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients
|
You, Xiaofan
|
|
|
27 |
C |
p. 254-259
|
artikel
|
| 27 |
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
|
D'Amico, Emanuele
|
|
|
27 |
C |
p. 324-326
|
artikel
|
| 28 |
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis
|
Crescenzo, F.
|
|
|
27 |
C |
p. 305-311
|
artikel
|
| 29 |
Emotional processing in RRMS patients: Dissociation between behavioural and neurophysiological response
|
Migliore, S.
|
|
|
27 |
C |
p. 344-349
|
artikel
|
| 30 |
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal
|
Weinkle, Laura
|
|
|
27 |
C |
p. 383-390
|
artikel
|
| 31 |
Factors influencing multiple sclerosis disease-modifying treatment prescribing decisions in the United Kingdom: A qualitative interview study
|
Cameron, Elaine
|
|
|
27 |
C |
p. 378-382
|
artikel
|
| 32 |
Headache characteristics in multiple sclerosis
|
Beckmann, Yesim
|
|
|
27 |
C |
p. 112-116
|
artikel
|
| 33 |
Health, honesty and happiness: Authenticity and anonymity in social media participation of individuals with multiple sclerosis
|
Eijkholt, Marleen
|
|
|
27 |
C |
p. 121-126
|
artikel
|
| 34 |
HIV infection associated neuromyelitis optica spectrum disorder: Clinical features, imaging findings, management and outcomes
|
Mathew, Thomas
|
|
|
27 |
C |
p. 289-293
|
artikel
|
| 35 |
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online
|
Lavorgna, Luigi
|
|
|
27 |
C |
p. 239-246
|
artikel
|
| 36 |
Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study
|
Zivadinov, Robert
|
|
|
27 |
C |
p. 65-73
|
artikel
|
| 37 |
Impact of pre-cooling therapy on the physical performance and functional capacity of multiple sclerosis patients: A systematic review
|
Kaltsatou, Antonia
|
|
|
27 |
C |
p. 419-423
|
artikel
|
| 38 |
Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience
|
Sammaraiee, Yezen
|
|
|
27 |
C |
p. 95-100
|
artikel
|
| 39 |
Lambert–Eaton myasthenic syndrome associated with alemtuzumab administration
|
Hoffman, B. Mark
|
|
|
27 |
C |
p. 131-132
|
artikel
|
| 40 |
Listeria monocytogenes rhombencephalitis in a patient with multiple sclerosis during fingolimod therapy
|
Tecellioglu, Mehmet
|
|
|
27 |
C |
p. 409-411
|
artikel
|
| 41 |
Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures
|
Fuchs, Tom A.
|
|
|
27 |
C |
p. 298-304
|
artikel
|
| 42 |
Mitochondrial DNA G15927A and G15928A variations in patients with multiple sclerosis
|
Andalib, Sasan
|
|
|
27 |
C |
p. 9-12
|
artikel
|
| 43 |
Multiple sclerosis and the risk of systemic venous thrombosis: A systematic review
|
Ahmed, Omnya
|
|
|
27 |
C |
p. 424-430
|
artikel
|
| 44 |
Multiple sclerosis registries in Europe – An updated mapping survey
|
Glaser, A.
|
|
|
27 |
C |
p. 171-178
|
artikel
|
| 45 |
Multiple sclerosis relapse presenting as an acute cardiomyopathy
|
Bayer, Alina D.
|
|
|
27 |
C |
p. 7-8
|
artikel
|
| 46 |
Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews
|
Matza, Louis S.
|
|
|
27 |
C |
p. 139-146
|
artikel
|
| 47 |
Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models
|
Wu, Yan
|
|
|
27 |
C |
p. 412-418
|
artikel
|
| 48 |
Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: A preliminary study of sixteen Senegalese cases
|
Gaye, Ndiaga Matar
|
|
|
27 |
C |
p. 179-183
|
artikel
|
| 49 |
No evidence of disease activity status over 3 years in a real-world cohort of relapsing remitting MS patients in Germany
|
Huhn, Konstantin
|
|
|
27 |
C |
p. 133-138
|
artikel
|
| 50 |
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis
|
Carotenuto, A.
|
|
|
27 |
C |
p. 1-6
|
artikel
|
| 51 |
Palmar pustular psoriasis associated with teriflunomide treatment
|
Negrotto, Laura
|
|
|
27 |
C |
p. 400-402
|
artikel
|
| 52 |
Paraneoplastic neuromyelitis optica associated with fever of unknown origin as an early manifestation: A case report
|
etemadifar, Masoud
|
|
|
27 |
C |
p. 200-202
|
artikel
|
| 53 |
Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis
|
Vinciguerra, C.
|
|
|
27 |
C |
p. 294-297
|
artikel
|
| 54 |
Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis
|
Jankowska-Lech, Irmina
|
|
|
27 |
C |
p. 260-268
|
artikel
|
| 55 |
Persistence and adherence to the new oral disease-modifying therapies for multiple sclerosis: A population-based study
|
Setayeshgar, Solmaz
|
|
|
27 |
C |
p. 364-369
|
artikel
|
| 56 |
Puberty onset and pediatric multiple sclerosis activity in boys
|
Young, Brenda
|
|
|
27 |
C |
p. 184-187
|
artikel
|
| 57 |
Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
|
Alcalá, Carmen
|
|
|
27 |
C |
p. 406-408
|
artikel
|
| 58 |
Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol
|
Conte, William L
|
|
|
27 |
C |
p. 397-399
|
artikel
|
| 59 |
Relative importance of physical and psychological factors to slowness in people with mild to moderate multiple sclerosis
|
Yang, Feng
|
|
|
27 |
C |
p. 81-90
|
artikel
|
| 60 |
Resolution of inflammation in neuromyelitis optica spectrum disorders
|
Wang, Xu
|
|
|
27 |
C |
p. 34-41
|
artikel
|
| 61 |
Response to the commentary “The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases” by Biasiotto G and Zanella I.✰
|
Tiloca, Cinzia
|
|
|
27 |
C |
p. 79-80
|
artikel
|
| 62 |
Sequential phases of RGC axonal and somatic injury in EAE mice examined using DTI and OCT
|
Nishioka, Christopher
|
|
|
27 |
C |
p. 315-323
|
artikel
|
| 63 |
Should our treatment target in MS include the intrathecal plasma cell response?
|
Giovannoni, Gavin
|
|
|
27 |
C |
p. A1-A2
|
artikel
|
| 64 |
Spanish validation of the telephone assessed Expanded Disability Status Scale and Patient Determined Disease Steps in people with multiple sclerosis
|
Solà-Valls, Nuria
|
|
|
27 |
C |
p. 333-339
|
artikel
|
| 65 |
Takotsubo syndrome triggered in the setting of multiple sclerosis: The need to monitor blood catecholamines and the CNS sympathetic input to the heart
|
Madias, John E.
|
|
|
27 |
C |
p. 391
|
artikel
|
| 66 |
The coexistence of recurrent cerebral tumefactive demyelinating lesions with longitudinally extensive transverse myelitis and demyelinating neuropathy
|
Ciron, Jonathan
|
|
|
27 |
C |
p. 223-225
|
artikel
|
| 67 |
The contribution of the instrumented Timed-Up-and-Go test to detect falls and fear of falling in people with multiple sclerosis
|
Hershkovitz, Leora
|
|
|
27 |
C |
p. 226-231
|
artikel
|
| 68 |
The effect of C9orf72 intermediate repeat expansions in neurodegenerative and autoimmune diseases
|
Biasiotto, Giorgio
|
|
|
27 |
C |
p. 42-43
|
artikel
|
| 69 |
The role of gluten in multiple sclerosis: A systematic review
|
Thomsen, Henriette Lynge
|
|
|
27 |
C |
p. 156-163
|
artikel
|
| 70 |
The role of phospholipase A2 in multiple Sclerosis: A systematic review and meta-analysis
|
Trotter, Austin
|
|
|
27 |
C |
p. 206-213
|
artikel
|
| 71 |
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
|
Severa, Martina
|
|
|
27 |
C |
p. 52-60
|
artikel
|
| 72 |
Tocilizumab in MOG-antibody spectrum disorder: a case report
|
Novi, G.
|
|
|
27 |
C |
p. 312-314
|
artikel
|
| 73 |
Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies
|
Mao, Zhifeng
|
|
|
27 |
C |
p. 247-253
|
artikel
|
| 74 |
Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control
|
Cehelyk, Eli K.
|
|
|
27 |
C |
p. 269-275
|
artikel
|
| 75 |
Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis
|
Eskyte, Ieva
|
|
|
27 |
C |
p. 370-377
|
artikel
|
| 76 |
Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics✰
|
Holland, D.P.
|
|
|
27 |
C |
p. 214-222
|
artikel
|
| 77 |
Use of eHealth and mHealth technology by persons with multiple sclerosis
|
Marrie, Ruth Ann
|
|
|
27 |
C |
p. 13-19
|
artikel
|
| 78 |
Which treatment strategies for polyrefractory Neuro-Behçet disease?
|
London, Frédéric
|
|
|
27 |
C |
p. 203-205
|
artikel
|
Tijdschrift beschrijving